Cost-Effectiveness of a Serum Biomarker Test for Risk-Stratified Liver Ultrasound Screening for Hepatocellular Carcinoma
Hannah Carter, Gary P. Jeffrey, Grant A. Ramm, Louisa G. Gordon
Topics & Concepts
MedicineCost effectivenessCohortHepatocellular carcinomaQuality-adjusted life yearPopulationWillingness to payRisk assessmentOncologyInternal medicineEnvironmental healthRisk analysis (engineering)MicroeconomicsEconomicsComputer scienceComputer securityHepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation